OPEN END TURBO SHORT - COOPER COMPANIES Share Price

Certificat

DE000MG2HFF6

Market Closed - Börse Stuttgart 18:58:54 24/05/2024 BST
0.051 EUR -3.77% Intraday chart for OPEN END TURBO SHORT - COOPER COMPANIES
Current month-49.52%
1 month-32.91%
Date Price Change
24/05/24 0.051 -3.77%
23/05/24 0.053 +60.61%
22/05/24 0.033 +6.45%
21/05/24 0.031 +24.00%
20/05/24 0.025 -16.67%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 06:58 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG2HFF
ISINDE000MG2HFF6
Date issued 17/04/2024
Strike 100.1 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.106
Lowest since issue 0.015

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
94.89 USD
Average target price
107.9 USD
Spread / Average Target
+13.70%
Consensus